Independent prescribing and Pharmacy First from autumn 2026

What NHS England has actually announced

A national NHS independent prescribing (IP) offer, where a suitably qualified pharmacist can prescribe rather than only supply under a patient group direction, has been announced for autumn 2026, most likely October. It is planned to extend the current Pharmacy First service and the Pharmacy Contraception Service (PCS) so that pharmacists can prescribe within them.

The important qualifier is that this is announced and planned, not operational. Nothing about it is live, and the detail is still being worked through. Treat any date as indicative until NHS England and Community Pharmacy England publish the service specification.

Up to five new prescribing-only pathways

Alongside the existing seven Pharmacy First clinical pathways, the offer is expected to introduce up to five new prescribing-only pathways. The specific conditions have not been finalised, and a clinical reference group is deciding which conditions are suitable.

Until that group reports, no one can say which conditions will be covered. Be cautious of any supplier or commentary that lists the new pathways as settled, because the clinical scope has not been confirmed.

What contractors would be paid

The published contractor payments for the IP offer are a £500 one-off set-up fee plus £525 a month towards infrastructure. That sits on top of, not instead of, the existing service fees.

For 2026/27 the Pharmacy First consultation fee stays at £17, with the fixed monthly payments unchanged (£500 for 20–29 consultations in a month, £1,000 for 30 or more). The Pharmacy Contraception Service remains £25 per consultation. You can see the full current position in our Pharmacy First payments guide.

Newly qualified pharmacists as prescribers from September 2026

Separately from the national service offer, from September 2026 newly qualified pharmacists will register as independent prescribers at the point of registration. This is a change to initial education and training, not a service specification, and it gradually increases the number of pharmacists who can prescribe from the start of their careers.

It does not, by itself, make the Pharmacy First IP offer live, and it does not change the prescribing status of pharmacists already on the register.

This is not the Pathfinder pilot

The IP offer should not be confused with the Pathfinder programme, a time-limited pilot that tested pharmacist prescribing in a limited number of sites and concluded on 31 December 2025. Pathfinder was a pilot; the autumn 2026 offer is a planned national service.

They are distinct pieces of work. Evidence and experience from Pathfinder do not mean the national offer is in place, and the pilot's conclusion is not the offer's start.

What it could mean for remote capacity

Prescribing does not change the rules on where a consultation happens. Six of the seven Pharmacy First clinical pathways can already be delivered by good-quality video (audio-only is not permitted for clinical pathways), and any pharmacist providing a remote consultation must be physically at registered pharmacy premises. See how remote delivery works.

If the IP offer proceeds, the same principle would apply: a pharmacist consulting remotely from registered premises could add consultation and, in time, prescribing capacity while the on-site Responsible Pharmacist stays in place and is never replaced. Whether a single off-site pharmacist can support a separate registered pharmacy in this way is still being confirmed with Community Pharmacy England and NHS England, so we do not present it as settled. We are building towards it and will describe it as available only once the service specification and operating model are published. If you want to plan ahead, a short demo is the easiest place to start.